Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지
DOI QR코드

DOI QR Code

Herbal Medicines in Autism Spectrum Disorder: A Scoping Review of Preclinical Evidence and Therapeutic Mechanisms

  • Ly Thi Huong Nguyen (Department of Neuropsychiatry, College of Korean Medicine, Dongguk University) ;
  • Byung-Soo Koo (Department of Neuropsychiatry, College of Korean Medicine, Dongguk University) ;
  • Jihong Lee (Department of Korean Pediatrics, College of Korean Medicine, Daegu Haany University) ;
  • In-Jun Yang (Department of Physiology, College of Korean Medicine, Dongguk University)
  • Received : 2025.09.15
  • Accepted : 2025.11.11
  • Published : 2025.12.25
Download PDF
⟨ Previous Next ⟩

Abstract

Herbal medicines present a promising therapeutic alternative for autism spectrum disorder (ASD), overcoming the limited efficacy and significant adverse effects associated with conventional drugs. This scoping review aims to summarize preclinical evidence on the use of herbal medicines in ASD treatment, focusing on types of animal models, intervention characteristics, behavioral outcomes, and mechanisms of action. A literature search was conducted in PubMed, Scopus, and Web of Science for studies published up to February 2025, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. This review included studies that were published in English and focused on herbal medicines in animal models of ASD, with evaluation of ASD-related behaviors. Quality assessment of the included studies was performed according to the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines 2.0. Fifty-four studies met the inclusion criteria, with 72% published from 2021 to 2025, predominantly in Asian countries (83%). Chemically induced models, particularly valproic acid-induced models (43%), were the most utilized. Single compounds (69%) were investigated more frequently than herbal extracts (22%) or traditional formulations (7%). Oral administration (48%) and therapeutic strategies (80%) were the predominant treatments. Behavioral assessments focused on social (78%) and anxiety-like behaviors (74%), with the hippocampus (43%) and cerebellum (28%) being the most frequently examined. Antioxidant (48%) and anti-inflammatory (39%) activities were the principal therapeutic mechanisms. Safety reporting was deemed to be inadequate in 81% of studies. These findings indicate that herbal medicines improve ASD symptoms primarily through modulating oxidative stress and inflammation. Future studies should address safety profiling and expanded mechanistic investigations for clinical translation.

Keywords

Acknowledgement

This work was supported by the Dongguk University Research Fund (2025) and the National Research Foundation of Korea (NRF-2021R1I1A2048979).

References

  1. Christensen DL, et al. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years-Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020. Mmwr-Morbidity and Mortality Weekly Report. 2023:72(2).
  2. Bjørklund G, Meguid NA, El-Bana MA, Tinkov AA, Saad K, Dadar M, Hemimi M, Skalny AV, Hosnedlová B, Kizek R, Osredkar J, Urbina MA, Fabjan T, El-Houfey AA, Kałużna-Czaplińska J, Gątarek P, Chirumbolo S. Oxidative Stress in Autism Spectrum Disorder. Mol Neurobiol. 2020:57(5):2314-32. https://doi.org/10.1007/s12035-019-01742-2
  3. Matta SM, Hill-Yardin EL, Crack PJ. The influence of neuroinflammation in Autism Spectrum Disorder. Brain Behav Immun. 2019:79:75-90. https://doi.org/10.1016/j.bbi.2019.04.037
  4. DeFilippis, M. and K.D. Wagner, Treatment of Autism Spectrum Disorder in Children and Adolescents. Psychopharmacol Bull. 2016:46(2):18-41. https://doi.org/10.64719/pb.4346
  5. Pan SY, Litscher G, Gao SH, Zhou SF, Yu ZL, Chen HQ, Zhang SF, Tang MK, Sun JN, Ko KM. Historical perspective of traditional indigenous medical practices: the current renaissance and conservation of herbal resources. Evid Based Complement Alternat Med. 2014:2014:525340. https://doi.org/10.1155/ecam.v2014.1
  6. Bhandari R, Paliwal JK, Kuhad A. Dietary Phytochemicals as Neurotherapeutics for Autism Spectrum Disorder: Plausible Mechanism and Evidence. Adv Neurobiol. 2020:24:615-46. https://doi.org/10.1007/978-3-030-30402-7
  7. Ban C, et al. Characterization of Ginkgo biloba Leaf Flavonoids as Neuroexocytosis Regulators. Molecules. 2020:25(8). https://doi.org/10.3390/molecules25081829
  8. Yang W, et al. Uncaria rhynchophylla and its Major Constituents on Central Nervous System: A Review on Their Pharmacological Actions. Curr Vasc Pharmacol. 2020:18(4):346-57. https://doi.org/10.2174/1570161117666190704092841
  9. Bang M, et al. Herbal Medicine Treatment for Children with Autism Spectrum Disorder: A Systematic Review. Evid Based Complement Alternat Med. 2017:2017:8614680. https://doi.org/10.1155/ecam.v2017.1
  10. Nicolini C, Fahnestock M. The valproic acid-induced rodent model of autism. Exp Neurol. 2018:299(Pt A):217-27. https://doi.org/10.1016/j.expneurol.2017.04.017
  11. Meyza KZ, et al. The BTBR T+ tf/J mouse model for autism spectrum disorders-in search of biomarkers. Behav Brain Res. 2013:251:25-34. https://doi.org/10.1016/j.bbr.2012.07.021
  12. Deb S, et al. Natural Products and Their Therapeutic Effect on Autism Spectrum Disorder. Adv Neurobiol. 2020:24:601-14. https://doi.org/10.1007/978-3-030-30402-7
  13. Gasparotto FM, et al. Herbal Medicine as an Alternative Treatment in Autism Spectrum Disorder: A Systematic Review. Curr Drug Metab. 2018:19(5):454-9. https://doi.org/10.2174/1389200219666171227202332
  14. Ratajczak HV. Theoretical aspects of autism: biomarkers--a review. J Immunotoxicol. 2011:8(1):80-94. https://doi.org/10.3109/1547691X.2010.538749
  15. Matelski L, J. Van de Water. Risk factors in autism: Thinking outside the brain. J Autoimmun. 2016:67:1-7. https://doi.org/10.1016/j.jaut.2015.11.003
  16. Percie du Sert N, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. BMJ Open Sci. 2020:4(1):e100115.
  17. Tricco AC, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018:169(7):467-73. https://doi.org/10.7326/M18-0850
  18. Okano H, et al. Ameliorating effect of continuous alpha-glycosyl isoquercitrin treatment starting from late gestation in a rat autism model induced by postnatal injection of lipopolysaccharides. Chem Biol Interact. 2022:351:109767. https://doi.org/10.1016/j.cbi.2021.109767
  19. Jayaprakash P, et al. Apigenin Alleviates Autistic-like Stereotyped Repetitive Behaviors and Mitigates Brain Oxidative Stress in Mice. Pharmaceuticals (Basel). 2024:17(4).
  20. Mehta R, Bhandari R, Kuhad A. Effects of catechin on a rodent model of autism spectrum disorder: implications for the role of nitric oxide in neuroinflammatory pathway. Psychopharmacology. 2021:238(11):3249-71. https://doi.org/10.1007/s00213-021-05941-5
  21. Jayaprakash P, et al. Curcumin Potentiates alpha7 Nicotinic Acetylcholine Receptors and Alleviates Autistic-Like Social Deficits and Brain Oxidative Stress Status in Mice. Int J Mol Sci. 2021:22(14). https://doi.org/10.3390/ijms22147251
  22. Mehra S, et al. Neuroprotective Efficacy of Fisetin Against VPA-Induced Autistic Neurobehavioral Alterations by Targeting Dysregulated Redox Homeostasis. J Mol Neurosci. 2023:73(6):403-22.
  23. Mehra S, et al. Gestational Fisetin Exerts Neuroprotection by Regulating Mitochondria-Directed Canonical Wnt Signaling, BBB Integrity, and Apoptosis in Prenatal VPA-Induced Rodent Model of Autism. Mol Neurobiol. 2024:61(7):4001-20.
  24. Kumar M, et al. Therapeutic efficacy of Genistein in activation of neuronal AC/cAMP/CREB/PKA and mitochondrial ETC-Complex pathways in experimental model of autism: Evidence from CSF, blood plasma and brain analysis. Brain Res. 2025:1846:149251.
  25. Khalaj R, Moghaddam A Zare HM. Hesperetin and it nanocrystals ameliorate social behavior deficits and oxido-inflammatory stress in rat model of autism. Int J Dev Neurosci. 2018:69:80-7. https://doi.org/10.1016/j.ijdevneu.2018.06.009
  26. Alhusain AF, et al. Salubrious effects of proanthocyanidins on behavioral phenotypes and DNA repair deficiency in the BTBR mouse model of autism. Saudi Pharm J. 2024:32(11):102187.
  27. Jiang P, et al. Puerarin attenuates valproate-induced features of ASD in male mice via regulating Slc7a11-dependent ferroptosis. Neuropsychopharmacology. 2024:49(3):497-507.
  28. Fan L, et al. Yigansan ameliorates maternal immune activation-induced autism-like behaviours by regulating the IL-17A/TRAF6/MMP9 pathway: Network analysis and experimental validation. Phytomedicine. 2024:128:155386.
  29. de Mattos BDS, et al. Quercetin prevents alterations of behavioral parameters, delta-aminolevulinic dehydratase activity, and oxidative damage in brain of rats in a prenatal model of autism. Int J Dev Neurosci. 2020:80(4):287-302. https://doi.org/10.1002/jdn.v80.4
  30. Moghaddam AH, et al. Preventive effect of quercetin-Loaded nanophytosome against autistic-like damage in maternal separation model: The possible role of Caspase-3, Bax/Bcl-2 and Nrf2. Behav Brain Res. 2023:441:114300.
  31. Bakheet SA, et al. Resveratrol Ameliorates Dysregulation of Th1, Th2, Th17, and T Regulatory Cell-Related Transcription Factor Signaling in a BTBR T+ tf/J Mouse Model of Autism. Mol Neurobiol. 2017:54(7):5201-12. https://doi.org/10.1007/s12035-016-0066-1
  32. Xie W, et al. Resveratrol ameliorates prenatal progestin exposure-induced autism-like behavior through ERβ activation. Mol Autism. 2018:9:43. https://doi.org/10.1186/s13229-018-0225-5
  33. Zeng X, et al. Resveratrol regulates Thoc5 to improve maternal immune activation-induced autism-like behaviors in adult mouse offspring. J Nutr Biochem. 2024:129:109638.
  34. Bhandari R, Kuhad A. Resveratrol suppresses neuroinflammation in the experimental paradigm of autism spectrum disorders. Neurochem Int. 2017:103:8-23. https://doi.org/10.1016/j.neuint.2016.12.012
  35. Shahrbabaki SSV, et al. Ameliorating age-dependent effects of resveratrol on VPA-induced social impairments and anxiety-like behaviors in a rat model of neurodevelopmental disorder. Neurotoxicology. 2023:96:154-65.
  36. Mahmoudian M, et al. Protective effects of rosmarinic acid against autistic-like behaviors in a mouse model of maternal separation stress: behavioral and molecular amendments. Naunyn Schmiedebergs Arch Pharmacol. 2024:397(10):7819-28.
  37. Mallan S, Singh S. Syringic acid alleviates valproic acid induced autism via activation of p38 mitogen-activated protein kinase: Possible molecular approach. Environ Toxicol. 2023:38(10):2400-15.
  38. Farzan M, et al. Protective effects of vanillic acid on autistic-like behaviors in a rat model of maternal separation stress: Behavioral, electrophysiological, molecular and histopathological alterations. Int Immunopharmacol. 2023:118:110112.
  39. Al-Amin MM, et al. Astaxanthin improves behavioral disorder and oxidative stress in prenatal valproic acid-induced mice model of autism. Behav Brain Res. 2015:286:112-21. https://doi.org/10.1016/j.bbr.2015.02.041
  40. Chen M, et al. Astragaloside IV ameliorates autism-like behaviors in BTBR mice by modulating Camk2n2-dependent OXPHOS and neurotransmission in the mPFC. J Adv Res. 2025.
  41. Seyedinia SA, et al. Saffron and crocin ameliorate prenatal valproic acid-induced autistic-like behaviors and brain oxidative stress in the male offspring rats. Metab Brain Dis. 2023:38(7):2231-41.
  42. Anand P, Kaur A, Singh S. Fucoxanthin mitigates valproic acid-induced autistic behavior through modulation of the AKT/GSK-3β signaling pathway. European Journal of Pharmacology. 2024:967.
  43. Erten F. Lycopene ameliorates propionic acid-induced autism spectrum disorders by inhibiting inflammation and oxidative stress in rats. J Food Biochem. 2021:45(10):e13922. https://doi.org/10.1111/jfbc.v45.10
  44. Sherawat K, et al. Neuroprotective Potential of Tanshinone-IIA in Mitigating Propionic Acidinduced Experimental Autism-like Behavioral and Neurochemical Alterations: Insights into c-JNK and p38MAPK Pathways. Curr Mol Pharmacol. 2024:17:e18761429326799.
  45. Xiong Y, et al. Thymol improves autism-like behaviour in VPA-induced ASD rats through the Pin1/p38 MAPK pathway. Int Immunopharmacol. 2023:117:109885.
  46. Kaplan JS, et al. Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome. Proc Natl Acad Sci USA. 2017:114(42):11229-34. https://doi.org/10.1073/pnas.1711351114
  47. Pedrazzi JFC, et al. Acute cannabidiol treatment reverses behavioral impairments induced by embryonic valproic acid exposure in male mice. Pharmacol Biochem Behav. 2025:247:173919. https://doi.org/10.1016/j.pbb.2024.173919
  48. Li X, et al. Cannabidiol attenuates seizure susceptibility and behavioural deficits in adult CDKL5(R59X) knock-in mice. Eur J Neurosci. 2024:59(12):3337-52.
  49. Patra PH, et al. Cannabidiol improves survival and behavioural co-morbidities of Dravet syndrome in mice. Br J Pharmacol. 2020:177(12):2779-92. https://doi.org/10.1111/bph.v177.12
  50. Staben J, et al. Cannabidiol and cannabis-inspired terpene blends have acute prosocial effects in the BTBR mouse model of autism spectrum disorder. Frontiers in Neuroscience. 2023:17.
  51. Liu QQ, et al. Lotusine ameliorates propionic acid-induced autism spectrum disorder-like behavior in mice by activating D1 dopamine receptor in medial prefrontal cortex. Phytother Res. 2024:38(2):1089-103.
  52. Luhach K, et al. Effect of papaverine on developmental hyperserotonemia induced autism spectrum disorder related behavioural phenotypes by altering markers of neuronal function, inflammation, and oxidative stress in rats. Clin Exp Pharmacol Physiol. 2021:48(4):614-25. https://doi.org/10.1111/cep.v48.4
  53. Luhach K, et al. Attenuation of neurobehavioural abnormalities by papaverine in prenatal valproic acid rat model of ASD. Eur J Pharmacol. 2021:890:173663. https://doi.org/10.1016/j.ejphar.2020.173663
  54. Pragnya B, Kameshwari JS, Veeresh B. Ameliorating effect of piperine on behavioral abnormalities and oxidative markers in sodium valproate induced autism in BALB/C mice. Behav Brain Res. 2014:270:86-94. https://doi.org/10.1016/j.bbr.2014.04.045
  55. Fujita Y, et al. Dietary intake of glucoraphanin during pregnancy and lactation prevents the behavioral abnormalities in the offspring after maternal immune activation. Neuropsychopharmacol Rep. 2020:40(3):268-74. https://doi.org/10.1002/npr2.v40.3
  56. Zhou L, et al. Ligustilide inhibits Purkinje cell ferritinophagy via the ULK1/NCOA4 pathway to attenuate valproic acid-induced autistic features. Phytomedicine. 2024:126:155443.
  57. Karimi P, et al. Umbelliprenin via increase in the MECP2 and attenuation of oxidative stress mitigates the autistic-like behaviors in mouse model of maternal separation stress. Front Pharmacol. 2023:14:1300310.
  58. Serra D, et al. Attenuation of Autism-like Behaviors by an Anthocyanin-Rich Extract from Portuguese Blueberries via Microbiota-Gut-Brain Axis Modulation in a Valproic Acid Mouse Model. Int J Mol Sci. 2022:23(16). https://doi.org/10.3390/ijms23169259
  59. Sandhya T, Sowjanya J, Veeresh B. Bacopa monniera (L.) Wettst ameliorates behavioral alterations and oxidative markers in sodium valproate induced autism in rats. Neurochem Res. 2012:37(5):1121-31. https://doi.org/10.1007/s11064-012-0717-1
  60. Zhang N, Wang ST, Yao L. Inhalation of Cananga odorata essential oil relieves anxiety behaviors in autism-like rats via regulation of serotonin and dopamine metabolism. J Integr Med. 2023:21(2):205-14.
  61. Banji D, et al. Amelioration of behavioral aberrations and oxidative markers by green tea extract in valproate induced autism in animals. Brain Res. 2011:1410:141-51. https://doi.org/10.1016/j.brainres.2011.06.063
  62. Park HY, et al. Humulus japonicus rescues autistic‑like behaviours in the BTBR T(+) Itpr3(tf)/J mouse model of autism. Mol Med Rep. 2021:23(6). https://doi.org/10.3892/mmr
  63. Gonzales EL, et al. Supplementation of Korean Red Ginseng improves behavior deviations in animal models of autism. Food Nutr Res. 2016:60:29245. https://doi.org/10.3402/fnr.v60.29245
  64. Amini-Khoei H, et al. Therapeutic Potential of Ocimum basilicum L. Extract in Alleviating Autistic-Like Behaviors Induced by Maternal Separation Stress in Mice: Role of Neuroinflammation and Oxidative Stress. Phytother Res. 2025:39(1):64-76. https://doi.org/10.1002/ptr.v39.1
  65. Amini F, et al. Hydroalcoholic extract of Passiflora incarnata improves the autistic-like behavior and neuronal damage in a valproic acid-induced rat model of autism. J Tradit Complement Med. 2023:13(4):315-24.
  66. Al-Radadi NS, et al. Plant-mediated green synthesis of gold nanoparticles using an aqueous extract of Passiflora ligularis, optimization, characterizations, and their neuroprotective effect on propionic acid-induced autism in Wistar rats. Saudi Pharm J. 2024:32(2):101921.
  67. Gouda B, et al. Extraction, Phytochemical profile, and neuroprotective activity of Phyllanthus emblica fruit extract against sodium valproate-induced postnatal autism in BALB/c mice. Heliyon. 2024:10(15):e34992.
  68. Yang X, et al. Supplementation with stigma maydis polysaccharide attenuates autism-like behaviors and improves gut function in valproic acid-induced autism model male rats. Int J Dev Neurosci. 2024:84(6):567-80.
  69. Guo Q, et al. Kami-shoyo-san ameliorates sociability deficits in ovariectomized mice, a putative female model of autism spectrum disorder, via facilitating dopamine D(1) and GABA(A) receptor functions. J Ethnopharmacol. 2019:236:231-9. https://doi.org/10.1016/j.jep.2019.03.010
  70. Guo Q, et al. Kami-shoyo-san improves ASD-like behaviors caused by decreasing allopregnanolone biosynthesis in an SKF mouse model of autism. PLoS One. 2019:14(1):e0211266. https://doi.org/10.1371/journal.pone.0211266
  71. Zhang M, et al. Luteolin in the Qi Bi Anshen decoction improves propionic acid-induced autism-like behavior in rats by inhibiting LRP1/MMP9. Phytomedicine. 2023:118:154965.
  72. Napolitano A, et al. Sex Differences in Autism Spectrum Disorder: Diagnostic, Neurobiological, and Behavioral Features. Front Psychiatry. 2022:13:889636. https://doi.org/10.3389/fpsyt.2022.889636
  73. Sullivan K, Stone WL, Dawson G. Potential neural mechanisms underlying the effectiveness of early intervention for children with autism spectrum disorder. Res Dev Disabil. 2014:35(11):2921-32. https://doi.org/10.1016/j.ridd.2014.07.027
  74. First MB, et al. An organization- and category-level comparison of diagnostic requirements for mental disorders in ICD-11 and DSM-5. World Psychiatry. 2021:20(1):34-51. https://doi.org/10.1002/wps.v20.1
  75. Troyb E, et al. Restricted and Repetitive Behaviors as Predictors of Outcome in Autism Spectrum Disorders. Journal of Autism and Developmental Disorders. 2016:46(4):1282-96. https://doi.org/10.1007/s10803-015-2668-2
  76. Balasco L, Provenzano G, Bozzi Y. Sensory Abnormalities in Autism Spectrum Disorders: A Focus on the Tactile Domain, From Genetic Mouse Models to the Clinic. Front Psychiatry. 2019:10:1016. https://doi.org/10.3389/fpsyt.2019.01016
  77. Habata K, et al. Relationship between sensory characteristics and cortical thickness/volume in autism spectrum disorders. Translational Psychiatry. 2021:11(1). https://doi.org/10.1038/s41398-021-01743-7
  78. Delmonte S, et al. Functional and structural connectivity of frontostriatal circuitry in Autism Spectrum Disorder. Front Hum Neurosci. 2013:7:430.
  79. Seguin D, et al. Amygdala subnuclei development in adolescents with autism spectrum disorder: Association with social communication and repetitive behaviors. Brain Behav. 2021:11(8):e2299. https://doi.org/10.1002/brb3.v11.8
  80. Usui N, Kobayashi H, Shimada S. Neuroinflammation and Oxidative Stress in the Pathogenesis of Autism Spectrum Disorder. Int J Mol Sci. 2023:24(6).
  81. Nadeem A, et al. Imbalance in pro-inflammatory and anti-inflammatory cytokines milieu in B cells of children with autism. Mol Immunol. 2022:141:297-304. https://doi.org/10.1016/j.molimm.2021.12.009
  82. Chen Z, et al. Neuroplasticity of children in autism spectrum disorder. Front Psychiatry. 2024:15:1362288.
  83. Hughes HK, Rose D, Ashwood P. The Gut Microbiota and Dysbiosis in Autism Spectrum Disorders. Curr Neurol Neurosci Rep. 2018:18(11):81. https://doi.org/10.1007/s11910-018-0887-6
  84. Devarkar VD. Traditional Herbal Approaches to the Management of Autism Spectrum Disorder (ASD): A Review. Plantae Scientia. 2025:8(1):9-14. https://doi.org/10.32439/ps.v8i1.9-14
  85. Aishworiya R, et al. An Update on Psychopharmacological Treatment of Autism Spectrum Disorder. Neurotherapeutics. 2022:19(1):248-62. https://doi.org/10.1007/s13311-022-01183-1